Conclusion MARS is one of the complementary methods that are safe and effective for patients with chronic liver failure.
结论MARS治疗慢性肝功能衰竭具有很好的临床效果和安全性，可作为辅助治疗慢性肝功能衰竭的方法之一。
Objective To evaluate the effect and safety of a single treatment using molecular adsorbent recirculating system (MARS) on patients with chronic liver failure.
目的评价分子吸附再循环系统(MARS)治疗慢性肝功能衰竭患者的临床疗效及安全性。
Objective To evaluate the effect of a single treatment and safety using molecular adsorbent recirculating system (MARS) in patients with chronic liver failure.
目的：评价分子吸附再循环系统(MARS)治疗慢性肝功能衰竭的临床疗效及其安全性。
To assess the value of the model for end-stage liver disease (MELD) on the short-term prognosis in the patients with chronic liver failure (chronic and severe hepatitis B).
探讨终末期肝病模型(MELD)评分系统对预测慢性重型乙型病毒性肝炎患者短期预后的临床应用价值。
Objective To analyze the prognostic factors for patients with acute-on-chronic liver failure, and to bulid a scoring system for assessment of the prognosis of liver failure.
目的对影响乙型慢加急性肝衰竭预后的单因素进行分析，探讨影响慢加急性肝衰竭患者预后的危险因素。
Acholic feces may occur with acute liver failure or progression of chronic disease.
急性肝功能衰竭或慢性疾病的进展可能会导致无胆汁粪便。
Chronic conditions. For example, if you have cancer, kidney or liver failure, or another chronic condition, you may be at risk of what's called anemia of chronic disease.
一些慢性病理状态癌症、肾衰竭、肝衰竭等病症会造成红细胞缺乏，进而引发慢性病性贫血。
Chronic severe poisoning was found in 1.17% of the patients and all of them died of liver failure.
慢性中度中毒1.17%，表现为重症肝病，均死于肝功能衰竭。
Objective: To establish a quantitative biochemical standard for evaluating the prognosis and the necessity of urgent liver transplantation in chronic hepatic failure (CHF).
目的：判断慢性肝衰竭预后的量化指标，了解患者是否有紧急肝移植的指征。
To investigate the risk factors of liver failure due to lamivudine resistance in the patients with chronic hepatitis B.
邓洪，顾琳，赵志新， 张晓红，彭晓谋，高志良探讨慢性乙型肝炎患者拉米夫定耐药后出现肝功能衰竭的危险因素。
End stage liver disease is the end of acute or chronic liver diseases, with the manifestations of the liver failure.
终末期肝病是急性或慢性肝病的终末阶段，常伴有肝衰竭的临床表现。
HBV can usually escape early and late immune response leading to chronic liver disease-chronic hepatitis B, liver cirrhosis, liver failure and hepatic cellular carcinoma.
HBV通常可以逃避早期和晚期免疫应答导致慢性肝脏疾病——慢性乙型肝炎、乙肝后肝硬化、肝衰竭、肝癌。
HBV can usually escape early and late immune response leading to chronic liver disease-chronic hepatitis B, liver cirrhosis, liver failure and hepatic cellular carcinoma.
HBV通常可以逃避早期和晚期免疫应答导致慢性肝脏疾病——慢性乙型肝炎、乙肝后肝硬化、肝衰竭、肝癌。
应用推荐